Loading
Everything in development, the medicines held by this cancer's subtypes, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for Urethral cancer, drawn from the whole corpus: 0 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
Nothing recorded in development for this cancer yet.
1 medicines on record are linked to one of the types below rather than to Urethral cancer itself. Grouped by the type that holds them; each list opens that type's own page.
No prospective trials; international registries and inclusion in urothelial and HPV-squamous basket trials are the response.
Late diagnosis mimicking benign stricture; urethroscopy for unexplained stricture or bleeding is the practical fix.
Balancing organ preservation with cure in proximal tumours; chemoradiation series are growing.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 4 changes by month →When this page itself was last checked or edited.
Applied by extrapolation to urothelial-type urethral carcinoma.
Gakis and colleagues pool multi-institutional data, showing benefit of perioperative chemotherapy and defining the EAU guideline.
Thiaudierre's description in a woman.